Hongmei M. Jing
49 Huayuan North Road
Haidian, 100191, China
Haidian, 100191, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 143 publications
Clinical features and management of GPRC5D-associated adverse events in novel GPRC5D × CD3 bispecific talquetamab-treated relapsed/refractory multiple myeloma patients: the MonumenTAL-1 China cohort experience.
Journal: Hematology (Amsterdam, Netherlands)
Published: September 01, 2026
A Comprehensive Landscape of B Symptoms in Mantle Cell Lymphoma Reveals Heterogeneity Associated With Different Primary Sites.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: July 09, 2026
Matching-Adjusted Indirect Comparison of Gecacitinib, Fedratinib, Pacritinib, and Momelotinib in Second-Line Myelofibrosis Therapy.
Journal: Hematological oncology
Published: April 27, 2026
Correction: A novel immune model predicts the prognosis of mantle cell lymphoma.
Journal: Frontiers in medicine
Published: March 31, 2026
Efficacy and safety of zanubrutinib combined with age-adapted bendamustine and rituximab followed by zanubrutinib maintenance therapy in elderly patients with mantle cell lymphoma: a retrospective analysis.
Journal: Leukemia & lymphoma
Published: March 07, 2026
Safety and Efficacy of Plerixafor in Poor Mobilizers With Lymphoma: A Multicenter, Prospective, Single-Arm Study.
Journal: American journal of hematology
Published: February 04, 2026
Hemophagocytic Lymphohistiocytosis After CAR T-Cell Therapy: A Systematic Review and Meta-Analysis.
Journal: American journal of hematology
Published: January 15, 2026
Clinical efficacy and safety of CLAE regimen for refractory/relapsed T cell acute lymphoblastic leukemia/lymphoma: a prospective, multicenter, single-arm study
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: December 17, 2025
A novel immune model predicts the prognosis of mantle cell lymphoma.
Journal: Frontiers in medicine
Published: November 21, 2025
Current progress of CDC20 in cancer development and targeting CDC20 for cancer therapy.
Journal: Carcinogenesis
Published: October 26, 2025
Clinical characteristics and prognosis of 52 patients with primary central nervous system lymphoma
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: October 14, 2025
Phase I/II Trial of the FLT3 Kinase Inhibitor XY0206 in Patients With Relapsed/Refractory Acute Myeloid Leukemia.
Journal: European journal of haematology
Published: October 10, 2025
Last Updated: 09/26/2026